Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fusco

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
Meningococcal vaccine development: a novel approachP C Fusco, M S Blake, F Michon
The Journal of Infectious Diseases|February 1, 1997
Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primatesP C Fusco, F Michon, J Y Tai, et al.
Infection and Immunity|August 1, 1978
In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factorsR E Isaacson, P C Fusco, C C Brinton, et al.
Developments in Biologicals|February 24, 2001
Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitopeF Michon, C H Huang, E K Farley, et al.
Vaccine|November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adultsP Richmond, D Goldblatt, P C Fusco, et al.
Vaccine|October 31, 1998
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccineP C Fusco, F Michon, M Laude-Sharp, et al.
Vaccine|October 21, 1998
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier proteinF Michon, P C Fusco, C A Minetti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|July 5, 2005
Meningococcal vaccine development: a novel approachP C Fusco, M S Blake, F Michon
The Journal of Infectious Diseases|February 1, 1997
Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primatesP C Fusco, F Michon, J Y Tai, et al.
Infection and Immunity|August 1, 1978
In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factorsR E Isaacson, P C Fusco, C C Brinton, et al.
Developments in Biologicals|February 24, 2001
Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitopeF Michon, C H Huang, E K Farley, et al.
Vaccine|November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adultsP Richmond, D Goldblatt, P C Fusco, et al.
Vaccine|October 31, 1998
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccineP C Fusco, F Michon, M Laude-Sharp, et al.
Vaccine|October 21, 1998
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier proteinF Michon, P C Fusco, C A Minetti, et al.
Pageof 1